Shida Yan
Papers
4
Total Citations
24
H-Index
3
About
Shida Yan is a head and neck surgical oncologist whose research sits at the intersection of minimally invasive surgery, immunotherapy, and oropharyngeal cancer management. Working primarily in the Chinese clinical context, Yan has emerged as a leading voice in the application of transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPSCC), examining its safety and efficacy across both HPV-positive and HPV-negative patient populations. Yan's most significant contributions center on pioneering neoadjuvant immunochemotherapy protocols combined with transoral surgery for HPV-associated oropharyngeal cancer. His phase II clinical trials investigating sintilimab — an anti-PD-1 checkpoint inhibitor — paired with platinum-doublet chemotherapy prior to TORS represent some of the earliest rigorous efforts in China to explore treatment de-escalation strategies for this increasingly prevalent disease. These studies have collectively accumulated over 24 citations since 2023, reflecting rapid uptake of his findings within the oncology community. Yan's work also illuminates how HPV status influences prognosis and informs surgical decision-making, contributing meaningfully to personalized treatment frameworks. His research is particularly valuable for clinicians seeking evidence-based approaches to balancing oncological efficacy with reduced treatment-related morbidity in younger, HPV-positive patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4